मुख्य सामग्री पर जाएँ

Altitude Acclimatization Planner

Get a personalized day-by-day ascent schedule to prevent altitude sickness

Planner

The Altitude Acclimatization Planner generates a safe, day-by-day ascent schedule for any high-altitude mountain objective. Altitude sickness (AMS, HACE, HAPE) is the leading preventable cause of death in high-altitude mountaineering, and proper acclimatization planning is the primary defense. This tool applies established medical guidelines to produce a personalized schedule.

The planner implements the 'climb high, sleep low' principle and the widely accepted guideline of ascending no more than 300-500m in sleeping altitude per day above 3,000m. It factors in the user's starting altitude, their target summit altitude, and whether they have previous high-altitude experience.

For popular peaks, the planner offers pre-built itineraries that match established routes. A Kilimanjaro planner produces the standard 7-day Machame route schedule, while an Everest Base Camp plan follows the classic teahouse trek with rest days at Namche Bazaar and Dingboche.

The planner includes a risk assessment dashboard showing the user's predicted AMS risk at each stage, plus emergency descent triggers with clear criteria for when to descend. The tool includes medical disclaimers and directs users to consult a travel medicine physician for prescription medications.

यह कैसे काम करता है

  1. Enter your target mountain or target summit altitude
  2. Enter your home altitude (where you normally live/sleep)
  3. Select your recent altitude exposure: None / Spent time above 3,000m in last 2 weeks / Spent time above 4,000m in last 2 weeks / Currently at altitude
  4. Select your high-altitude experience level: None / Some (1-3 trips above 4,000m) / Experienced (regular trips above 5,000m) / Expert (8,000m experience)
  5. Optionally select a pre-built route template for popular mountains
  6. Click "Generate Schedule" to see the day-by-day plan
  7. Review the itinerary with daily hiking altitude, sleeping altitude, and rest day recommendations
  8. View the risk assessment dashboard showing predicted AMS risk at each stage

आज़माएं

max) max = d.climb_to; if (d.sleep_at > max) max = d.sleep_at; } return max || 1; }, get totalDays() { return this.days.length; }, get summitDay() { let max = 0; let dayNum = 0; for (const d of this.days) { if (d.climb_to > max) { max = d.climb_to; dayNum = d.day; } } return dayNum; }, barHeight(altitude) { return Math.max(4, (altitude / this.maxAltitude) * 100); }, riskColor(risk) { const colors = { low: 'bg-green-100 text-green-700 dark:bg-green-900/40 dark:text-green-400', moderate: 'bg-amber-100 text-amber-700 dark:bg-amber-900/40 dark:text-amber-400', high: 'bg-red-100 text-red-700 dark:bg-red-900/40 dark:text-red-400' }; return colors[risk] || colors.low; }, riskDot(risk) { const colors = { low: 'bg-green-500', moderate: 'bg-amber-500', high: 'bg-red-500' }; return colors[risk] || colors.low; } }">

कोई मार्ग उपलब्ध नहीं।

उपयोग के मामले

संबंधित शब्द

Acclimatization Death Zone

How to Use

  1. 1
    Enter target summit elevation and approach details

    Specify your final objective altitude, the elevation at which you will begin your acclimatization ascent, and whether you are using a siege-style or alpine-style approach. The planner uses these inputs to generate a staged ascent schedule.

  2. 2
    Review the day-by-day ascent schedule

    Examine the generated itinerary showing daily sleeping elevations, rest days, and acclimatization rotations. The schedule follows the "climb high, sleep low" principle — spending daytime hours at progressively higher elevations while returning to lower sleeping altitudes to stimulate erythropoietin production and enhance acclimatization.

  3. 3
    Adjust for individual response indicators

    Modify the schedule based on your AMS symptom tracking using the Lake Louise Score. If you score 3 or above on the Lake Louise questionnaire — indicating mild to moderate AMS — the planner recommends extending the rest day or descending 300–500 m before continuing the ascent.

About

Altitude acclimatization is the complex physiological process by which the human body adapts to reduced partial pressure of oxygen at elevation. The process involves increased ventilatory rate, progressive alkalosis correction by renal bicarbonate excretion, elevated erythropoietin (EPO) secretion driving erythropoiesis, enhanced myoglobin concentration in muscle tissue, and structural cardiovascular adaptations that collectively improve oxygen delivery to metabolically active tissues. These adaptations unfold over days to weeks and cannot be artificially compressed without increasing the risk of life-threatening altitude illness.

The Wilderness Medical Society's evidence-based guidelines recommend ascending no faster than 300–500 m per day of sleeping elevation above 3,000 m, with a rest day (no net elevation gain) every 3–4 days. The "climb high, sleep low" protocol, refined over decades of Himalayan expedition practice, exploits the diurnal cycle by exposing climbers to progressively higher daytime elevations while preserving sleep quality at lower altitudes. Acclimatization rotations — ascending to higher camps and returning to base — are the primary tool for stimulating adaptation without accumulating physiological debt.

The Lake Louise Score and its 2018 revised criteria provide a standardized, field-applicable instrument for monitoring individual acclimatization progress and detecting early AMS. Systematic daily scoring allows expedition members to identify poor responders who need extended rest or descent before symptoms progress to HACE or HAPE. The Altitude Acclimatization Planner integrates these evidence-based thresholds into an adjustable day-by-day schedule, enabling expedition planners to build in the flexibility — and the discipline — that successful high-altitude ascents require.

FAQ

What is the Lake Louise Score, and how is it used to assess altitude sickness?
The Lake Louise Score (LLS) is the most widely used clinical instrument for diagnosing acute mountain sickness (AMS), validated in studies published in the journal High Altitude Medicine and Biology. It assesses five symptoms — headache, gastrointestinal symptoms, fatigue or weakness, dizziness or lightheadedness, and difficulty sleeping — on a 0–3 scale, with a total score of 3 or more in the presence of headache indicating AMS. A 2018 revision by the Lake Louise AMS Score Consensus Committee removed the functional status component from the scoring and re-centered headache as a required criterion. The score is used both for field diagnosis and as a research endpoint in high-altitude medicine trials.
What is the "climb high, sleep low" principle, and why does it accelerate acclimatization?
"Climb high, sleep low" is the foundational principle of altitude acclimatization, first systematically described by physiologist Charles Houston and expedition physician Tom Hornbein in the context of Himalayan expeditions. Spending daytime hours at higher altitudes stimulates hypoxic physiological responses — including increased erythropoietin (EPO) secretion by renal peritubular cells, driving red blood cell production — while sleeping at a lower elevation reduces overnight hypoxic stress on the central nervous system, improving sleep quality and recovery. The net effect is progressive adaptation to altitude without the accumulative CNS deprivation that occurs when climbers sleep continuously at high altitude. The Wilderness Medical Society recommends not increasing sleeping elevation by more than 300–500 m per day above 3,000 m.
What are HACE and HAPE, and how do they differ from AMS?
High-altitude cerebral oedema (HACE) and high-altitude pulmonary oedema (HAPE) represent the life-threatening progression of altitude illness beyond AMS. HACE is characterized by ataxia, altered consciousness, and papilloedema, resulting from cerebral vasogenic oedema; it is treated with immediate descent, supplemental oxygen, and dexamethasone 8 mg followed by 4 mg every six hours. HAPE is a non-cardiogenic pulmonary oedema manifesting as dyspnea at rest, productive cough, and hypoxemia disproportionate to altitude; it is the leading cause of altitude-related death and responds to descent, supplemental oxygen, and — in descent-impossible scenarios — portable hyperbaric therapy. Unlike AMS, both HACE and HAPE can develop without prior AMS symptoms. The Wilderness Medical Society's 2014 guidelines define their diagnostic criteria and treatment algorithms.
How does acetazolamide work as an acclimatization aid?
Acetazolamide (Diamox, 125–250 mg twice daily) inhibits carbonic anhydrase, reducing bicarbonate reabsorption in the renal proximal tubule. This produces a mild metabolic acidosis that stimulates increased ventilation, effectively raising alveolar oxygen tension and accelerating the ventilatory acclimatization that normally takes several days at altitude. Randomized controlled trials reviewed in the Cochrane Database of Systematic Reviews confirm its efficacy in preventing and treating AMS at doses of 125 mg or higher taken 24 hours before ascent. Acetazolamide is a sulfonamide derivative and is contraindicated in patients with sulfa drug allergy; common side effects include perioral tingling and increased urination. It does not substitute for proper staged ascent but can serve as a prophylactic adjunct on rapid ascent itineraries.
What is the recommended acclimatization schedule for an 8,000-metre peak?
No universally agreed schedule exists, but the practices codified in expedition medicine literature and followed by professional Himalayan climbing teams typically involve: arrival at base camp (~5,300 m) after a multi-day trek from lower elevations; a first rotation to Camp 1 (approximately 6,000 m) with a return to base camp for 3–5 rest days; a second rotation to Camp 2 (~6,500 m) and a brief carry to Camp 3 (~7,200 m) before returning to base; followed by a period of complete rest at base camp or below, sometimes including a descent to a lower elevation such as Namche Bazaar (3,440 m) to facilitate recovery. The summit push typically begins 5–7 days after the final rotation, with the entire pre-summit acclimatization process taking 4–6 weeks for a previously unacclimatized climber. This schedule reflects published research showing that adequate acclimatization reduces HAPE incidence and improves summit success rates.

अक्सर पूछे जाने वाले प्रश्न